Safety Study of Levocetirizine and Fexofenadine

NCT01586091 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Pruritus
Chronic Urticaria
Allergic Rhinitis

Interventions

DRUG: Levocetirizine Oral Tablet
DRUG: Fexofenadine 60 Mg Oral Tablet
DRUG: Placebo Oral Tablet

Sponsor

Charite University, Berlin, Germany